A rare case of voluminous brain abscess due to Actinomyces meyeri and Aggregatibacter aphrophilus: is there any evidence for a prolonged antibiotic oral relay?

J Infect Chemother. 2021 Aug;27(8):1234-1237. doi: 10.1016/j.jiac.2021.02.005. Epub 2021 Feb 12.

Abstract

We present the case of a patient with a voluminous cerebral abscess caused by Aggregatibacter aphrophilus and Actinomyces meyeri occurring a week post dental scaling. Both these bacteria are rarely involved in brain abscesses, and so far, cases of cerebral actinomyces have mostly been treated surgically and with intravenous (IV) antibiotics for 3-4 months, then put on oral antibiotic therapy with penicillin or amoxicillin for a further 3-12 months. Our patient underwent drainage through craniotomy and was subsequently put on intravenous ceftriaxone for 3 months accompanied by brain imaging control at the end of this period which showed complete regression of the abscess. Following parenteral treatment, no oral antibiotics were given since pharmacokinetic properties do not allow to attain high tissue concentration in the brain. This treatment gave excellent results.

Keywords: Actinomyces meyeri; Aggregatibacter aphrophilus; Brain abscess; HACEK.

Publication types

  • Case Reports

MeSH terms

  • Actinomycetaceae
  • Aggregatibacter aphrophilus*
  • Anti-Bacterial Agents / therapeutic use
  • Brain Abscess* / drug therapy
  • Ceftriaxone / therapeutic use
  • Humans

Substances

  • Anti-Bacterial Agents
  • Ceftriaxone

Supplementary concepts

  • Schaalia meyeri